Neurocrine Biosciences, Inc. (NASDAQ: NBIX)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 189.54 (4.04 / 2.18%) | 166.80 (-18.70 / -10.08%) | 166.38 (-0.42 / -0.25%) |
| 31-Jul 09:19 | 31-Jul 16:00 | 31-Jul 18:30 |
Sector: Healthcare || Industry: Drug Manufacturers - Specialty & Generic
| Previous Close | 185.50 | Year Low | 122.14 |
| Open | 184.34 | Year High | 186.12 |
| Day Low | 164.56 | Price Avg 50 | 167.11 |
| Day High | 185.55 | Price Avg 200 | 145.76 |
| Volume | 4.52 M | Market Cap | 16.77 B |
News
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| NBIX | -10.08 | -4.28 | -1.03 | 26.68 | 22.59 | 30.08 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/30/2026 | AMC | NBIX | Neurocrine Biosciences | Q2 2026 | EPS | 1.56 | 1.65 | ||||
| 07/30/2026 | AMC | NBIX | Neurocrine Biosciences | Q2 2026 | REV | 875.76 M | 687.50 M | ||||
| 05/05/2026 | AMC | NBIX | Neurocrine Biosciences | Q1 2026 | EPS | 1.15 | 1.94 | 68.70 | 0.70 | 177.10 | |
| 05/05/2026 | AMC | NBIX | Neurocrine Biosciences | Q1 2026 | REV | 770.20 M | 814.50 M | 5.75 | 572.60 M | 42.25 | |
| 02/11/2026 | AMC | NBIX | Neurocrine Biosciences | Q4 2025 | EPS | 1.89 | 1.88 | -0.53 | 1.69 | 11.20 | |
| 02/11/2026 | AMC | NBIX | Neurocrine Biosciences | Q4 2025 | REV | 792.47 M | 805.50 M | 1.64 | 627.70 M | 28.33 | |
| 10/28/2025 | AMC | NBIX | Neurocrine Biosciences | Q3 2025 | EPS | 1.59 | 2.17 | 36.48 | 1.81 | 19.90 | |
| 10/28/2025 | AMC | NBIX | Neurocrine Biosciences | Q3 2025 | REV | 746.05 M | 794.90 M | 6.55 | 622.10 M | 27.78 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 05/29/2026 | NBIX | RBC Capital | Outperform | Outperform | Maintain |
| 05/08/2026 | NBIX | JP Morgan | Overweight | Overweight | Maintain |
| 05/07/2026 | NBIX | Truist Securities | Buy | Buy | Maintain |
| 05/06/2026 | NBIX | RBC Capital | Outperform | Outperform | Maintain |
| 05/06/2026 | NBIX | Morgan Stanley | Equal Weight | Equal Weight | Maintain |
| 05/06/2026 | NBIX | Wedbush | Outperform | Outperform | Maintain |
| 05/06/2026 | NBIX | Guggenheim | Buy | Buy | Maintain |
| 05/06/2026 | NBIX | Piper Sandler | Overweight | Overweight | Maintain |
| 05/06/2026 | NBIX | Citigroup | Buy | Buy | Maintain |
| 04/22/2026 | NBIX | Leerink Partners | Outperform | Outperform | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|
Sign-Up to see the full list of CATALYSTS in the Calendars
